Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study

Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study

The aim of the study was to evaluate the safety and efficacy of a new chemo-radiotherapy regimen for patients with locally advanced pancreatic cancer (LAPC). Patients were treated as follows: gemcitabine 1000 mg/m<sup>2</sup> on day 1, and oxaliplatin 100 mg/m<sup>2</sup> on...

Full description

Bibliographic Details
Main Authors: Alessandro Passardi, Emanuela Scarpi, Elisa Neri, Elisabetta Parisi, Giulia Ghigi, Giorgio Ercolani, Andrea Gardini, Giuliano La Barba, Flavia Pagan, Andrea Casadei-Gardini, Martina Valgiusti, Fabio Ferroni, Giovanni Luca Frassineti, Antonino Romeo
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Cancers
Subjects:
pancreatic cancer
neoadjuvant therapy
GEMOX
radiotherapy
Online Access:https://www.mdpi.com/2072-6694/11/5/663

Internet

https://www.mdpi.com/2072-6694/11/5/663

Similar Items